Xiao-Jun Lin
Overview
Explore the profile of Xiao-Jun Lin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
1809
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lin X, Chang M, Cao M, Sohail M, Qiao M, Zhang X
Carbohydr Polym
. 2024 Sep;
346:122616.
PMID: 39245526
Traditional Fenton principles for degrading polysaccharides, including chondroitin sulfate (CS), are fraught with limitations, such as strict pH-dependence, higher temperature requirements, desulfurization, and environmentally perilous. In this study, an effective...
2.
Zheng J, Lin X, Xu H, Sohail M, Chen L, Zhang X
Biotechnol Adv
. 2024 Jun;
74:108394.
PMID: 38857660
Glycosaminoglycans (GAGs) are a family of structurally complex heteropolysaccharides that play pivotal roles in biological functions, including the regulation of cell proliferation, enzyme inhibition, and activation of growth factor receptors....
3.
Li X, Zhou E, Dong X, Zhao C, Han Y, Cui B, et al.
Eur J Med Res
. 2023 Dec;
28(1):606.
PMID: 38115156
Objective: In the treatment of resectable pancreatic cancer, adjuvant chemotherapy is viewed as essential. However, it is yet unclear how well adjuvant chemotherapy works at different illness stages. This study...
4.
Li X, Huang G, Xu Z, Zhao C, Dong X, Cui B, et al.
J Transl Med
. 2023 Dec;
21(1):911.
PMID: 38098005
Objective: Pancreatic cancer is an aggressive malignancy with high mortality, and cancer cell stemness and related drug resistance are considered important contributors to its poor prognosis. The objective of this...
5.
Li X, Zhou E, Zhao C, Cui B, Dong X, Du H, et al.
Cancer Med
. 2023 Dec;
12(24):21742-21750.
PMID: 38059559
Background: The malignancy of cholangiocarcinoma is highly pronounced, and it exhibits a propensity for recurrence and metastasis even in the presence of standard chemotherapy. The efficacy of adjuvant chemotherapy combined...
6.
Li X, Zhao C, Zhou E, Lin X
BMC Cancer
. 2022 Nov;
22(1):1159.
PMID: 36357848
Objective: Adjuvant chemotherapy is necessary for radical resection of intrahepatic cholangiocarcinoma (ICC) with a high risk of recurrence (T2-4, N1). However, its use in the treatment of early-stage ICC remains...
7.
Yang H, Luo Y, Zhang L, He K, Lin X
Inflamm Res
. 2022 Aug;
71(9):1055-1066.
PMID: 35913584
Background: Sepsis is an abnormal immune-inflammatory response that is mainly caused by infection. It can lead to life-threatening organ dysfunction and death. Severely damaged tissue cells will release intracellular histones...
8.
Jia C, Feng Z, Lin X, Cui Q, Han S, Jin Y, et al.
Sci Rep
. 2022 Jul;
12(1):11119.
PMID: 35778441
With the increase in extremely low birth weight (ELBW) infants, their outcome attracted worldwide attention. However, in China, the related studies are rare. The hospitalized records of ELBW infants discharged...
9.
Ni L, Han Y, Wang S, Lin X, Wang Y, Yan H, et al.
Pediatr Res
. 2022 Apr;
93(1):267-273.
PMID: 35459765
Background: Peroxisomal proliferator-activated receptors (PPARs) and microRNAs (miRNAs) play important roles in the development of fetuses, whereas expression changes of PPARs and three miRNAs (miR-17, miR-27b and miR-34a) and whether...
10.
Lin X, Xu X, Zhang H, Ding M, Cao W, Yu Q, et al.
Placenta
. 2021 Dec;
118:1-9.
PMID: 34972066
Introduction: Fetal growth and development depend on metabolic energy from placental mitochondria. However, the impact of placental mitochondria on the occurrence of macrosomia remains unclear. We aimed to explore the...